CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-01 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 56,856.47 |
| 2025-02-01 | Rice Derica W Director | Grant or award · Deferred Share Units | +3,562.43 | $58.95 | $210K | 30,681.17 |
| 2025-02-01 | Price Paula A Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 20,434.09 |
| 2025-02-01 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 7,826.7 |
| 2025-02-01 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 17,835.64 |
| 2025-02-01 | Haller Julia A Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 32,223.09 |
| 2025-02-01 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 14,488.41 |
| 2025-02-01 | Arduini Peter J Director | Grant or award · Deferred Share Units | +3,562.34 | $58.95 | $210K | 60,937.92 |
| 2025-02-01 | Hickey Benjamin President, RayzeBio Org. | Option exercise | +10,078 | 10,858 | ||
| 2025-02-01 | Hickey Benjamin President, RayzeBio Org. | Shares withheld for taxes | −3,725 | $58.95 | $220K | 7,133 |
| 2025-02-01 | Hickey Benjamin President, RayzeBio Org. | Option exercise · Restricted Stock Units | −10,078 | 20,158 | ||
| 2025-02-01 | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Option exercise | +2,543 | 7,829 | ||
| 2025-02-01 | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Shares withheld for taxes | −833 | $58.95 | $49K | 6,996 |
| 2025-02-01 | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Option exercise · Restricted Stock Units | −2,543 | 2,543 | ||
| 2024-12-31 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +618.81 | $56.56 | $35K | 30,796.37 |
| 2024-12-31 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +884.02 | $56.56 | $50K | 52,748.6 |
| 2024-12-31 | Rice Derica W Director | Grant or award · Deferred Share Units | +663.01 | $56.56 | $38K | 26,841.24 |
| 2024-12-31 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +552.51 | $56.56 | $31K | 4,220.71 |
| 2024-12-31 | Arduini Peter J Director | Grant or award · Deferred Share Units | +596.71 | $56.56 | $34K | 56,788.28 |
| 2024-11-04 | Holzer Phil M SVP and Controller | Sale | −700 | $55.62 | $39K | 11,760 |
Page 27 of 40 · 799 trades